Sun Pharma Advanced Research Share Price

₹ 189.30

-₹3.27 (-1.7%)
1D
Last updated 20 Nov, 2026, 10:20 IST
NSE: SPARC
|
Diversified

Sun Pharma Advanced Research Share Price Today

As of 20 Nov 2026, Sun Pharma Advanced Research share price is ₹189.30. The stock opened at ₹192.57, compared to its previous close of ₹192.57. During today's trading session, Sun Pharma Advanced Research share price moved in the range of ₹189.20 to ₹192.80, with an average price of ₹191.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹108.00 and a high of ₹289.00. On the performance front, Sun Pharma Advanced Research share price has increased by 7.12% over the last six months and is up 47.31% on a year-on-year basis.

Share price over the last 1 day fell from 191.43 to 189.24, ranging between 189.24 and 191.93.

₹189.20
1.70% down today
₹192.80
1D LOW
1D HIGH

Sun Pharma Advanced Research Stock Insights

Latest Earning
Op Profit TrendUp by 553.06% YoY
Latest Earning
Net Profit TrendUp by 553.48% YoY
Latest Earning
Revenue TrendUp by 2469.49% YoY
Stock Performance
OutperformingBeat Nifty by 41.39 % in last 1 year
Shareholding Pattern
DIIDII decreased stake by 6.56%
Shareholding Pattern
FIIFII decreased stake by 4.05%
Technical Indicators
MACD CrossThe MACD line crossed below the signal line on 1 Day interval.
Sun Pharma Advanced Research stock performance
Open₹192.57
High₹192.80
Low₹189.20
Prev. close₹192.57
Sun Pharma Advanced Research trading activity
Volume1,44,860
Average traded price₹190.73
Last traded time10:20:45 20 Nov
Last traded quantity12

Circuit
L
H
₹154.06
₹231.08
52-week
L
H
₹108.00
₹289.00
Mkt Cap Cr
6,169.16

P/E
3.77

P/B
4.28

ROA
97.74%
ROE
113.43%

ROCE
112.36%

Quick Ratio
2.47

EV/EBITDA
3.12

Based on fundamentals, this stock's

Performance: 3 out of 5, Neutral
Performance
Neutral
SPARC performance is moderate compared to markets
Valuation: 2 out of 5, Expensive
Valuation
Expensive
SPARC PE is significantly higher than its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
SPARC earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,49,227.4940.895.039.61%13.79%18.65%2.3123.48
Divis Laboratories2,93,873.7288.2416.4915.31%18.69%23.83%3.558.55
Torrent Pharmaceuticals1,76,412.7183.659.564.7%11.42%11.37%0.7533.58
Laurus Labs1,24,379.8793.3520.5211.58%22.11%20.91%0.6852.91
Zydus Lifesciences1,19,201.7127.714.297.63%15.1%14.86%0.9116.08
Dr. Reddy's Laboratories1,16,603.9142.253.04.79%7.21%8.58%1.3519.55
Cipla1,11,730.9240.23.246.6%8.18%10.8%2.521.17
Mankind Pharma1,08,630.8648.176.27.82%12.76%14.68%0.7426.14
Aurobindo Pharma1,03,625.5625.992.636.46%10.13%12.76%1.1512.45
Lupin90,038.7117.513.813.08%21.65%24.54%1.4210.11

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Sun Pharma Advanced Research Company Background

ISIN
INE232I01014
Sector Market Cap
₹ 6,169.16 Cr

Sun Pharma Advanced Research Company Limited is an India-based clinical-stage biopharmaceutical company that focuses on developing therapeutics to improve standards of care for patients worldwide. The Company’s therapeutic focus is in the area of oncology, neurology and immunology. Its lead oncology programs include vodobatinib (SCO-088), a BCR-ABL targeting tyrosine kinase inhibitor for refractory chronic myelogenous leukemia, and an anti-MUC-1 antibody-drug conjugate (ADC) with the potential to treat multiple cancers. The Company’s other programs include Sezaby for the treatment of neonatal seizures, Vodobatinib for the treatment of neurodegenerative disorders (SCC-138), Vibozilimod for the treatment of autoimmune disorders (SCD-044), SCD-153 for the treatment of alopecia areata, SBO-154 for multiple cancer indications and SCO-155 for treatment of cancer. SBO-154 is an anti MUC1 ADC being developed for multiple tumor types expressing MUC1.

Sun Pharma Advanced Research Financial Highlights

  • Revenue: Sun Pharma Advanced Research reported revenue of ₹1,890.12 crore in FY26 vs ₹73.56 crore in FY25. It showed an increase of 2,469.49% on a yearly basis.
  • Operating Profit: Sun Pharma Advanced Research reported an operating profit of ₹1,553.01 crore in FY26 vs ₹342.78 crore in FY25. It showed an increase of 553.06% on a year-on-year basis.
  • Net Profit: Sun Pharma Advanced Research reported a net profit of ₹1,553.20 crore in FY26 vs ₹342.51 crore in FY25. It showed an increase of 553.48% on a yearly basis.

Sun Pharma Advanced Research Quarterly Result Highlights

  • Sun Pharma Advanced Research reported revenue of ₹53.65 crore in Sep 2026, compared with ₹63.58 crore in Jun 2026, representing a decrease of 15.62% on a quarter-on-quarter (QoQ) basis.
  • Sun Pharma Advanced Research reported an operating loss of ₹24.31 crore in Sep 2026, compared with ₹20.67 crore in Jun 2026, representing a decrease of 17.61% on a quarter-on-quarter (QoQ) basis.
  • Sun Pharma Advanced Research reported a loss of ₹24.39 crore in Sep 2026, compared with ₹20.78 crore in Jun 2026, reflecting a decrease of 17.37% on a QoQ basis.
  • The earnings per share (EPS) of Sun Pharma Advanced Research stood at ₹47.86 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
65.67%
FII
3.75%
Other DII
0.01%
Retail and other
30.48%
Mutual funds
0.10%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20262.04%
May 20262.47%
Jun 20263.90%
Sep 20263.75%

Sun Pharma Advanced Research Investment Returns

1 day
+1.29%

1 week
-9.31%

1 month
+4.05%

1 year
+47.31%

3 years
-22.49%

5 years
-27.07%

Sun Pharma Advanced Research Share Price History

Sun Pharma Advanced Research share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
19 Nov 26
₹190.65 / ₹192.57
+1.29%
18 Nov 26
₹192.64 / ₹190.12
-1.61%
17 Nov 26
₹195.00 / ₹193.24
-1.33%
16 Nov 26
₹205.84 / ₹195.84
-4.86%
Show more

Sun Pharma Advanced Research Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,879.17₹71.77₹75.55₹238.78
Other Income₹10.95₹1.79₹29.47₹10.88
Total Revenue₹1,890.12₹73.56₹105.01₹249.66
Total Expenses₹324.75₹416.34₹491.85₹472.24
Profit Before Tax₹1,553.01-₹342.78-₹386.83-₹222.58
Tax-₹0.19-₹0.27₹0.38₹0.00
Profit After Tax₹1,553.20-₹342.51-₹387.21-₹222.58
EPS - Basic₹47.86-₹10.55-₹11.93-₹7.82
EPS - Diluted₹47.86-₹10.55-₹11.93-₹7.82

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,553.01-₹342.78-₹386.83-₹222.58
Income before WC changes₹1,594.17-₹322.26-₹397.74-₹215.59
Change in Assets-₹1,850.30₹2.92-₹47.88₹5.40
Change in Liabilities-₹14.29-₹49.78₹20.54₹135.71
Change in WC-₹1,864.59-₹46.86-₹27.33₹141.11
Cash flow from Operations-₹238.78-₹360.29-₹429.19-₹69.12
Cash flow from Investing-₹23.50₹157.66₹391.53-₹548.28
Cash flow from Financing₹261.39₹199.26₹42.41₹616.76
Total Cash Flow-₹0.89-₹3.38₹4.74-₹0.64
Cash (Start of the year)₹1.96₹5.33₹0.58₹1.22
Cash (End of the year)₹1.16₹1.96₹5.33₹0.58

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹308.45₹309.34₹245.66₹375.16
Current Assets₹1,862.43₹26.20₹269.39₹454.96
Total Assets₹2,170.88₹335.53₹515.04₹830.13
Current Liabilities₹754.11₹374.24₹265.06₹178.95
Net Current Asset₹1,108.32-₹348.04₹4.33₹276.02
Non-Current Liabilities₹77.94₹178.24₹124.23₹138.41
Equity Capital₹1,338.83-₹216.95₹125.76₹512.78
Total Equity & Liabilities₹2,170.88₹335.53₹515.04₹830.13

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,879.17₹71.77₹75.55₹238.78
Other Income₹10.83₹1.79₹29.47₹10.88
Total Revenue₹1,890.00₹73.56₹105.01₹249.66
Total Expenses₹325.50₹418.78₹493.12₹472.24
Profit Before Tax₹1,552.13-₹345.22-₹388.11-₹222.58
Tax₹0.00₹0.00₹0.00₹0.00
Profit After Tax₹1,552.13-₹345.22-₹388.11-₹222.58
EPS - Basic₹47.83-₹10.64-₹11.96-₹7.82
EPS - Diluted₹47.83-₹10.64-₹11.96-₹7.82

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,552.13-₹345.22-₹388.11-₹222.58
Income before WC changes₹1,593.27-₹326.40-₹399.44-₹215.59
Change in Assets-₹1,850.28-₹19.94-₹25.34₹5.40
Change in Liabilities-₹13.52-₹26.86-₹0.54₹135.71
Change in WC-₹1,863.80-₹46.80-₹25.88₹141.11
Cash flow from Operations-₹238.89-₹362.41-₹429.43-₹69.12
Cash flow from Investing-₹23.51₹157.66₹391.11-₹548.28
Cash flow from Financing₹261.53₹200.88₹42.80₹616.76
Total Cash Flow-₹0.87-₹3.87₹4.48-₹0.64
Cash (Start of the year)₹1.19₹5.06₹0.58₹1.22
Cash (End of the year)₹0.32₹1.19₹5.06₹0.58

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹306.61₹304.02₹239.93₹375.16
Current Assets₹1,861.38₹25.26₹246.41₹454.96
Total Assets₹2,167.99₹329.28₹486.33₹830.13
Current Liabilities₹756.83₹373.72₹243.89₹178.95
Net Current Asset₹1,104.55-₹348.46₹2.52₹276.02
Non-Current Liabilities₹77.58₹176.17₹117.59₹138.41
Equity Capital₹1,333.59-₹220.62₹124.86₹512.78
Total Equity & Liabilities₹2,167.99₹329.28₹486.33₹830.13
* All values are in INR Crore
Sun Pharma Advanced Research market depth
Bid quantityBid priceAsk priceAsk quantity
59189.21189.2243
50189.2189.2530
3189.19189.2812
3189.18189.2965
14189.16189.368
Total bid quantity129
Total ask quantity218
Sun Pharma Advanced Research technical summary
Bearish indicators1
Neutral indicators5
Bullish indicators2
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
47.49
Neutral

ATR (14)
9.85
Neutral

STOCH(9,6)
6.73
Bullish

STOCH RSI (14)
31.33
Neutral

ADX(9)
25.26
Bearish

UO(9)
40.99
Neutral

ROC(12)
8.58
Bullish

WillR(14)
-60.09
Neutral
Period
Simple value
Exponential vaue

5D
195.52
195.01

10D
200.19
195.73

20D
190.29
193.7

50D
192.35
194.11

100D
205.52
194.21
Volume trend — traded volume by day
20 Nov1L
19 Nov6L
18 Nov6L
17 Nov8L
16 Nov10L
13 Nov10L
Average7L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Sun Pharma Advanced Research
Diversified
Add Stock
Add Another

Mutual Funds Invested in Sun Pharma Advanced Research

Fund name
AUM
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
0.45%

Bandhan BSE Healthcare Index Fund
0.09%

Bandhan Nifty Total Market Index Fund
0.01%

Sun Pharma Advanced Research Returns Calculator

Sun Pharma Advanced Research Share Price FAQs












Please be aware that Sun Pharma Advanced Research stock prices are subject to continuous fluctuations due to various factors.